These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

221 related items for PubMed ID: 17928813

  • 1. Nasal Colivelin treatment ameliorates memory impairment related to Alzheimer's disease.
    Yamada M, Chiba T, Sasabe J, Terashita K, Aiso S, Matsuoka M.
    Neuropsychopharmacology; 2008 Jul; 33(8):2020-32. PubMed ID: 17928813
    [Abstract] [Full Text] [Related]

  • 2. Amyloid-beta causes memory impairment by disturbing the JAK2/STAT3 axis in hippocampal neurons.
    Chiba T, Yamada M, Sasabe J, Terashita K, Shimoda M, Matsuoka M, Aiso S.
    Mol Psychiatry; 2009 Feb; 14(2):206-22. PubMed ID: 18813209
    [Abstract] [Full Text] [Related]

  • 3. A humanin derivative, S14G-HN, prevents amyloid-beta-induced memory impairment in mice.
    Tajima H, Kawasumi M, Chiba T, Yamada M, Yamashita K, Nawa M, Kita Y, Kouyama K, Aiso S, Matsuoka M, Niikura T, Nishimoto I.
    J Neurosci Res; 2005 Mar 01; 79(5):714-23. PubMed ID: 15678515
    [Abstract] [Full Text] [Related]

  • 4. Colivelin ameliorates amyloid β peptide-induced impairments in spatial memory, synaptic plasticity, and calcium homeostasis in rats.
    Wu MN, Zhou LW, Wang ZJ, Han WN, Zhang J, Liu XJ, Tong JQ, Qi JS.
    Hippocampus; 2015 Mar 01; 25(3):363-72. PubMed ID: 25332198
    [Abstract] [Full Text] [Related]

  • 5. [Gly14]-Humanin Protects Against Amyloid β Peptide-Induced Impairment of Spatial Learning and Memory in Rats.
    Yuan L, Liu XJ, Han WN, Li QS, Wang ZJ, Wu MN, Yang W, Qi JS.
    Neurosci Bull; 2016 Aug 01; 32(4):374-82. PubMed ID: 27306655
    [Abstract] [Full Text] [Related]

  • 6. Secreted calmodulin-like skin protein ameliorates scopolamine-induced memory impairment.
    Hayashi M, Tajima H, Hashimoto Y, Matsuoka M.
    Neuroreport; 2014 Jun 18; 25(9):725-9. PubMed ID: 23797156
    [Abstract] [Full Text] [Related]

  • 7. The multiple T-maze in vivo testing of the neuroprotective effect of humanin analogues.
    Kunesová G, Hlavácek J, Patocka J, Evangelou A, Zikos C, Benaki D, Paravatou-Petsotas M, Pelecanou M, Livaniou E, Slaninova J.
    Peptides; 2008 Nov 18; 29(11):1982-7. PubMed ID: 18647630
    [Abstract] [Full Text] [Related]

  • 8. Targeting the JAK2/STAT3 axis in Alzheimer's disease.
    Chiba T, Yamada M, Aiso S.
    Expert Opin Ther Targets; 2009 Oct 18; 13(10):1155-67. PubMed ID: 19663649
    [Abstract] [Full Text] [Related]

  • 9. PPARγ agonist pioglitazone improves scopolamine-induced memory impairment in mice.
    Xiang GQ, Tang SS, Jiang LY, Hong H, Li Q, Wang C, Wang XY, Zhang TT, Yin L.
    J Pharm Pharmacol; 2012 Apr 18; 64(4):589-96. PubMed ID: 22420664
    [Abstract] [Full Text] [Related]

  • 10. The memory ameliorating effects of INM-176, an ethanolic extract of Angelica gigas, against scopolamine- or Aβ(1-42)-induced cognitive dysfunction in mice.
    Park SJ, Jung JM, Lee HE, Lee YW, Kim DH, Kim JM, Hong JG, Lee CH, Jung IH, Cho YB, Jang DS, Ryu JH.
    J Ethnopharmacol; 2012 Sep 28; 143(2):611-20. PubMed ID: 22846435
    [Abstract] [Full Text] [Related]

  • 11. Protective Effects of Colivelin Against Alzheimer's Disease in a PDAPP Mouse Model.
    Yin R, Yin K, Guo Z, Zhang Z, Chen L, Cao L, Li Y, Wei Y, Fu X, Shi X.
    Cell Physiol Biochem; 2016 Sep 28; 38(3):1138-46. PubMed ID: 26964005
    [Abstract] [Full Text] [Related]

  • 12. Development of a femtomolar-acting humanin derivative named colivelin by attaching activity-dependent neurotrophic factor to its N terminus: characterization of colivelin-mediated neuroprotection against Alzheimer's disease-relevant insults in vitro and in vivo.
    Chiba T, Yamada M, Hashimoto Y, Sato M, Sasabe J, Kita Y, Terashita K, Aiso S, Nishimoto I, Matsuoka M.
    J Neurosci; 2005 Nov 02; 25(44):10252-61. PubMed ID: 16267233
    [Abstract] [Full Text] [Related]

  • 13. S14G-Humanin ameliorates Abeta25-35-induced behavioral deficits by reducing neuroinflammatory responses and apoptosis in mice.
    Miao J, Zhang W, Yin R, Liu R, Su C, Lei G, Li Z.
    Neuropeptides; 2008 Nov 02; 42(5-6):557-67. PubMed ID: 18929410
    [Abstract] [Full Text] [Related]

  • 14. Inhibition of central angiotensin converting enzyme ameliorates scopolamine induced memory impairment in mice: role of cholinergic neurotransmission, cerebral blood flow and brain energy metabolism.
    Tota S, Nath C, Najmi AK, Shukla R, Hanif K.
    Behav Brain Res; 2012 Jun 15; 232(1):66-76. PubMed ID: 22460064
    [Abstract] [Full Text] [Related]

  • 15. Ameliorating effect of spinosin, a C-glycoside flavonoid, on scopolamine-induced memory impairment in mice.
    Jung IH, Lee HE, Park SJ, Ahn YJ, Kwon G, Woo H, Lee SY, Kim JS, Jo YW, Jang DS, Kang SS, Ryu JH.
    Pharmacol Biochem Behav; 2014 May 15; 120():88-94. PubMed ID: 24582850
    [Abstract] [Full Text] [Related]

  • 16. Enhancement of nose-to-brain delivery of basic fibroblast growth factor for improving rat memory impairments induced by co-injection of β-amyloid and ibotenic acid into the bilateral hippocampus.
    Feng C, Zhang C, Shao X, Liu Q, Qian Y, Feng L, Chen J, Zha Y, Zhang Q, Jiang X.
    Int J Pharm; 2012 Feb 28; 423(2):226-34. PubMed ID: 22193058
    [Abstract] [Full Text] [Related]

  • 17. [Gly(14)]-Humanin improved the learning and memory impairment induced by scopolamine in vivo.
    Mamiya T, Ukai M.
    Br J Pharmacol; 2001 Dec 28; 134(8):1597-9. PubMed ID: 11739234
    [Abstract] [Full Text] [Related]

  • 18. Ameliorative effects of yokukansan on learning and memory deficits in olfactory bulbectomized mice.
    Yamada M, Hayashida M, Zhao Q, Shibahara N, Tanaka K, Miyata T, Matsumoto K.
    J Ethnopharmacol; 2011 Jun 01; 135(3):737-46. PubMed ID: 21513784
    [Abstract] [Full Text] [Related]

  • 19. Chronic nicotine restores normal Aβ levels and prevents short-term memory and E-LTP impairment in Aβ rat model of Alzheimer's disease.
    Srivareerat M, Tran TT, Salim S, Aleisa AM, Alkadhi KA.
    Neurobiol Aging; 2011 May 01; 32(5):834-44. PubMed ID: 19464074
    [Abstract] [Full Text] [Related]

  • 20. Ellagic acid ameliorates learning and memory deficits in a rat model of Alzheimer's disease: an exploration of underlying mechanisms.
    Kiasalari Z, Heydarifard R, Khalili M, Afshin-Majd S, Baluchnejadmojarad T, Zahedi E, Sanaierad A, Roghani M.
    Psychopharmacology (Berl); 2017 Jun 01; 234(12):1841-1852. PubMed ID: 28303372
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.